Predictive factors for survival in borderline resectable and locally advanced pancreatic cancer: are these really two different entities?

Abstract Background The treatment of borderline resectable (BR) and locally advanced (LA) pancreatic ductal adenocarcinoma (PDAC) has evolved with a wider application of neoadjuvant chemotherapy (NACHT). The aim of this study was to identify predictive factors for survival in BR and LA PDAC. Methods...

全面介紹

書目詳細資料

Principais autores:	Luís Filipe Abreu de Carvalho, Filip Gryspeerdt, Niki Rashidian, Kobe Van Hove, Lambertine Maertens, Suzane Ribeiro, Anne Hoorens, Frederik Berrevoet
格式:	Artigo
語言:	Inglês
出版:	BMC 2023-09-01
叢編:	BMC Surgery
主題:	Pancreatic cancer Borderline resectable pancreatic cancer Locally advanced pancreatic cancer Neoadjuvant chemotherapy FOLFIRINOX
在線閱讀:	https://doi.org/10.1186/s12893-023-02200-6
標簽:	添加標簽 沒有標簽, 成為第一個標記此記錄!